Award details

Optimizing DNA based vaccination against FMDV in sheep and pigs

ReferenceBBS/E/I/00000962
Principal Investigator / Supervisor Dr Paul Barnett
Co-Investigators /
Co-Supervisors
Institution The Pirbright Institute
DepartmentThe Pirbright Institute Department
Funding typeResearch
Value (£) 105,084
StatusCompleted
TypeInstitute Project
Start date 01/09/2002
End date 31/08/2006
Duration48 months

Abstract

Our objectives will be to identify the best ways of optimizing the efficacy of DNA vaccines to FMDV in sheep and in pigs. Efficient DNA vaccines to FMDV could replace current inactivated vaccines and emergency vaccines, depending on EU policy of FMDV eradication programmes. As a potential emergency vaccine, the optimized DNA vaccination strategies will be tested for their ability to induce early protective immunity, following preferably only one DNA injection. The various parameters tested will include several FMDV antigens, a new generation of plasmids, promising adjuvants, several routes of administration and homologous (DNA/DNA) versus heterlogous (DNA/protein) prime-boost regimens. Protective immunity will be evaluated in tow major target species for FMD: sheep and pigs.

Summary

unavailable
Committee Closed Committee - Animal Sciences (AS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file